KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting
Conditions: GIST – Gastrointestinal Stromal Tumor; GIST; GIST Metastatic Cancer; Gastro Intestinal Stromal Tumour; Gastrointestinal Tumors

Interventions: Drug: KQB198; Drug: Imatinib (Gleevec)

Sponsors: Kumquat Biosciences Inc.

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 18, 2026Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments